{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:19:22Z","timestamp":1787066362441,"version":"build-2736575974"},"reference-count":32,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["GNT1141398"],"award-info":[{"award-number":["GNT1141398"]}]},{"name":"Australian National Health and Medical Research Council","award":["GNT1166499"],"award-info":[{"award-number":["GNT1166499"]}]},{"name":"Australian National Health and Medical Research Council","award":["GNT2002670"],"award-info":[{"award-number":["GNT2002670"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,3,2]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>People who inject drugs (PWID) are at risk of invasive infections such as bloodstream infections, endocarditis, osteomyelitis and septic arthritis. Such infections require prolonged antibiotic therapy, but there is limited evidence about the optimal care model to deliver to this population. The Epidemiology and Management of invasive infections among people who Use drugs (EMU) study aims to (1) describe the current burden, clinical spectrum, management and outcomes of invasive infections in PWID; (2) determine the impact of currently available models of care on completion of planned antimicrobials for PWID admitted to hospital with invasive infections and (3) determine postdischarge outcomes of PWID admitted with invasive infections at 30 and 90 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>EMU is a prospective multicentre cohort study of Australian public hospitals who provide care to PWIDs with invasive infections. All patients who have injected drugs in the previous six\u2009months and are admitted to a participating site for management of an invasive infection are eligible. EMU has two components: (1) EMU-Audit will collect information from medical records, including demographics, clinical presentation, management and outcomes; (2) EMU-Cohort will augment this with interviews at baseline, 30 and 90 days post-discharge, and data linkage examining readmission rates and mortality. The primary exposure is antimicrobial treatment modality, categorised as inpatient intravenous antimicrobials, outpatient antimicrobial therapy, early oral antibiotics or lipoglycopeptide. The primary outcome is confirmed completion of planned antimicrobials. We aim to recruit 146 participants over a 2-year period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>EMU has been approved by the Alfred Hospital Human Research Ethics Committee (Project number 78815.) EMU-Audit will collect non-identifiable data with a waiver of consent. EMU-Cohort will collect identifiable data with informed consent. Findings will be presented at scientific conferences and disseminated by peer-review publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ACTRN12622001173785; Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-070236","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T13:22:59Z","timestamp":1680528179000},"page":"e070236","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology and Management of invasive infections among people who Use drugs (EMU): protocol for a prospective, multicentre cohort study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0447-7917","authenticated-orcid":false,"given":"Lucy O","family":"Attwood","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, the Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellissa","family":"Bryant","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia"},{"name":"Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue J","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vujovic","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Higgs","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia"},{"name":"Department of Public Health, La Trobe University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S","family":"Doyle","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia"},{"name":"Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Stewardson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, the Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"2025101813184141000_13.4.e070236.1","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3201\/eid2308.170439","article-title":"Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997-2016","volume":"23","author":"Lewer","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2025101813184141000_13.4.e070236.2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa149"},{"key":"2025101813184141000_13.4.e070236.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.11.029"},{"key":"2025101813184141000_13.4.e070236.4","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy132","article-title":"Infectious diseases physicians\u2019 perspectives regarding injection drug use and related infections, United States, 2017","volume":"5","author":"Rapoport","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2025101813184141000_13.4.e070236.5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/jiz133","article-title":"Opioids and infectious diseases: a converging public health crisis","volume":"220","author":"Schwetz","year":"2019","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"2025101813184141000_13.4.e070236.6","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.1093\/infdis\/jiaa012","article-title":"Trends in morbidity, mortality, and cost of hospitalizations associated with infectious disease sequelae of the opioid epidemic","volume":"222","author":"Coyle","year":"2020","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"2025101813184141000_13.4.e070236.7","doi-asserted-by":"crossref","first-page":"S458","DOI":"10.1093\/infdis\/jiaa129","article-title":"Not just endocarditis: hospitalizations for selected invasive infections among persons with opioid and stimulant use diagnoses-north Carolina, 2010-2018","volume":"222","author":"Sredl","year":"2020","journal-title":"J Infect Dis"},{"key":"2025101813184141000_13.4.e070236.8","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1424"},{"key":"2025101813184141000_13.4.e070236.9","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2025101813184141000_13.4.e070236.10","doi-asserted-by":"publisher","DOI":"10.7326\/M18-2124"},{"key":"2025101813184141000_13.4.e070236.11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.hlc.2017.03.166","article-title":"The current epidemiology of injecting drug use-associated infective endocarditis in victoria, australia in the midst of increasing crystal methamphetamine use","volume":"27","author":"Wright","year":"2018","journal-title":"Heart Lung Circ"},{"key":"2025101813184141000_13.4.e070236.12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242165","article-title":"Population-Based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018","volume":"15","author":"Capizzi","year":"2020","journal-title":"PLoS One"},{"key":"2025101813184141000_13.4.e070236.13","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciz1061","article-title":"The changing epidemiology of candidemia in the United States: injection drug use as an increasingly common risk factor-active surveillance in selected sites, United States, 2014-2017","volume":"71","author":"Zhang","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025101813184141000_13.4.e070236.14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5694\/mja2.51623","article-title":"Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient-centred multidisciplinary care","volume":"217","author":"Attwood","year":"2022","journal-title":"Med J Aust"},{"key":"2025101813184141000_13.4.e070236.15","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/add.14892","article-title":"Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis","volume":"115","author":"Lewer","year":"2020","journal-title":"Addiction"},{"key":"2025101813184141000_13.4.e070236.16","doi-asserted-by":"crossref","first-page":"108057","DOI":"10.1016\/j.drugalcdep.2020.108057","article-title":"Incidence and treatment costs of severe bacterial infections among people who inject heroin: a cohort study in south london, england","volume":"212","author":"Lewer","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2025101813184141000_13.4.e070236.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.10.004"},{"key":"2025101813184141000_13.4.e070236.18","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","article-title":"Bacterial infections associated with substance use disorders, large cohort of United States hospitals, 2012-2017","volume":"71","author":"McCarthy","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025101813184141000_13.4.e070236.19","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz028","article-title":"Dalbavancin as secondary therapy for serious Staphylococcus aureus infections in a vulnerable patient population","volume":"6","author":"Bryson-Cahn","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025101813184141000_13.4.e070236.20","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-020-00452-z","article-title":"Oritavancin for the treatment of complicated gram-positive infection in persons who inject drugs","volume":"21","author":"Ahiskali","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"2025101813184141000_13.4.e070236.21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40121-019-0247-0","article-title":"Dalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive gram-positive infections","volume":"8","author":"Bork","year":"2019","journal-title":"Infect Dis Ther"},{"key":"2025101813184141000_13.4.e070236.22","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa293","article-title":"Use of a standardized dalbavancin approach to facilitate earlier hospital discharge for vulnerable patients receiving prolonged inpatient antibiotic therapy","volume":"7","author":"Vazquez Deida","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025101813184141000_13.4.e070236.23","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz274","article-title":"Long-Acting lipoglycopeptides: \u201c lineless antibiotics \u201d for serious infections in persons who use drugs","volume":"6","author":"Morrisette","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"2025101813184141000_13.4.e070236.24","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy194","article-title":"Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature","volume":"5","author":"Suzuki","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2025101813184141000_13.4.e070236.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2025101813184141000_13.4.e070236.26","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/cit612","article-title":"Fda guidance for ABSSSI trials: implications for conducting and interpreting clinical trials","volume":"58 Suppl 1","author":"Itani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2025101813184141000_13.4.e070236.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2025101813184141000_13.4.e070236.28","unstructured":"Australian Commission on Safety and Quality in Health Care . Australian hospital patient experience question set. Sydney, New South Wales: ACSQHC; 2022. Available: www.safetyandquality.gov.au\/our-work\/indicators-measurement-and-reporting\/australian-hospital-patient-experience-question-set"},{"key":"2025101813184141000_13.4.e070236.29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa365"},{"key":"2025101813184141000_13.4.e070236.30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/dar.13525","article-title":"Acute injection-related infections requiring hospitalisation among people who inject drugs: clinical features, microbiology and management","volume":"41","author":"Langham","year":"2022","journal-title":"Drug Alcohol Rev"},{"key":"2025101813184141000_13.4.e070236.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.02.018"},{"key":"2025101813184141000_13.4.e070236.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-019-0285-7","article-title":"\u201cMaybe if I stop the drugs, then maybe the\u2019\u2019d care?\u201d -hospital care experiences of people who use drugs","volume":"16","author":"Chan Carusone","year":"2019","journal-title":"Harm Reduct J"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-070236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:18:51Z","timestamp":1760818731000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-070236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,3]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/bmjopen-2022-070236"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-070236","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}